Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |